CSIMarket



Amgen Inc.  (AMGN)
Other Ticker:  
 
 
 

AMGN's vs. Competition, Income Growth by Segments

(Income Q 3 Growth Rates)



COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN Aranesp - -
Enact Holdings Inc. Generic pharmaceutical products -96.06 % -97.36 %
HOSPIRA, INC. Injectable Pharmaceutical - -
APROX. MARKET   SUBTOTAL -96.06 % -97.36 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN ENBREL - -
Abbvie Inc. HUMIRA - -
Abbott Laboratories Established Pharmaceutical Products 10.63 % 2.91 %
Allergan plc Eye Care Pharmaceuticals - -
Biogen Inc. AVONEX - -
Biogen Inc. TYSABRI - -
Biogen Inc. TECFIDERA - -
Biogen Inc. PLEGRIDY - -
Bristol myers Squibb Company ORENCIA - -
Johnson and Johnson REMICADE - -
Merck and Co. Inc. Remicade - -
Pfizer Inc Arthritis & pain - -
Pfizer Inc All other - -
APROX. MARKET   SUBTOTAL 10.63 % 2.91 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN EPOGEN TM - -
Abbvie Inc. HUMIRA - -
Abbott Laboratories Established Pharmaceutical Products 10.63 % 2.91 %
Enact Holdings Inc. Branded pharmaceutical products 1484.4 % -68.05 %
Allergan plc Skin Care - -
Bristol myers Squibb Company ORENCIA - -
Celgene Corp ABRAXANE - -
Johnson and Johnson PROCRIT - -
Johnson and Johnson REMICADE - -
Johnson and Johnson VELCADE - -
Eli Lilly And Company Oncology - -
Eli Lilly And Company Cardiovascular - -
Merck and Co. Inc. Zetia - -
Pfizer Inc Arthritis & pain - -
Pfizer Inc Oncology - -
APROX. MARKET   SUBTOTAL 260.72 % -61.25 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN Neulasta - -
Enact Holdings Inc. Generic pharmaceutical products -96.06 % -97.36 %
HOSPIRA, INC. Injectable Pharmaceutical - -
APROX. MARKET   SUBTOTAL -96.06 % -97.36 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN Other product sales - -
Abbvie Inc. HUMIRA - -
Abbott Laboratories Established Pharmaceutical Products 10.63 % 2.91 %
Agile Therapeutics Inc Total - -
Bristol myers Squibb Company Other - -
Bristol myers Squibb Company ORENCIA - -
Bristol myers Squibb Company Eliquis - -
Johnson and Johnson REMICADE - -
Eli Lilly And Company Endocrinology - -
Merck and Co. Inc. Zocor - -
Merck and Co. Inc. CozaarHyzaar - -
Merck and Co. Inc. Januvia - -
Mylan N v Total -13.41 % 155.27 %
Pfizer Inc Arthritis & pain - -
Pfizer Inc Cardiovascular & metabolic diseases - -
Teva Pharmaceutical Industries Limited Total -86.56 % -78.48 %
APROX. MARKET   SUBTOTAL -52.89 % -18.18 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN Prolia - -
APROX. MARKET   SUBTOTAL - -
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN Sensipar TM - -
Enact Holdings Inc. Branded pharmaceutical products 1484.4 % -68.05 %
Bristol myers Squibb Company SPRYCEL - -
Celgene Corp ABRAXANE - -
Johnson and Johnson PROCRIT - -
Johnson and Johnson VELCADE - -
Eli Lilly And Company Oncology - -
Eli Lilly And Company Cardiovascular - -
Merck and Co. Inc. Zetia - -
Pfizer Inc Oncology - -
APROX. MARKET   SUBTOTAL 1484.4 % -68.05 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Amgen Inc. AMGN Vectibix - -
Celgene Corp ABRAXANE - -
Johnson and Johnson VELCADE - -
Eli Lilly And Company Oncology - -
Merck and Co. Inc. Other - -
Pfizer Inc Oncology - -
APROX. MARKET   SUBTOTAL - -



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BDL's Profile

Stock Price

BDL's Financials

Business Description

Fundamentals

Charts & Quotes

BDL's News

Suppliers

BDL's Competitors

Customers & Markets

Economic Indicators

BDL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071